Mod­er­na stands by its Covid vac­cine IP af­ter de­ci­sion ax­ing two patents

Mod­er­na says its long-run­ning patent dis­pute with Pfiz­er and BioN­Tech isn’t over, even af­ter a de­ci­sion by an ad­min­is­tra­tive tri­bunal that in­val­i­dat­ed two of its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER